Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indinavir for Classical Kaposi's Sarcoma
NCT00362310Phase 2Completed
- Sponsor
- Istituto Superiore di Sanità
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indinavir in Kaposi's sarcoma (KS), sponsored by Istituto Superiore di Sanità. Primary endpoints: Tumor Response Rate and Duration of Response. Started Jun 2003; status: completed.
02
Drugs
indinavir
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00362310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362310.